The Foundation Approach to Drug Discovery
Apr 23, 2012, 04:00 AM
by
Michael Croft
The Atlantic | There's been much debate about the best drug discovery business model, with the weaknesses of both academia and pharma made painfully clear. But perhaps the best business model is being practiced by translation-focused disease foundations.
April 23, 2012 | There's been much debate about the best drug discovery business model, with the weaknesses of both academia and pharma made painfully clear. But perhaps the best business model is being practiced by translation-focused disease foundations. These foundations may be able to bridge academia and pharma and get better drugs to their patients faster and more cost effectively. The Atlantic